Endo 'Made Out Like A Bandit' With Opana Deal, Buyers Say
By Lauraann Wood · June 30, 2022, 10:17 PM EDT
Opana ER buyers told an Illinois federal jury Thursday that Endo Pharmaceuticals raked in profits by striking an unlawful settlement to delay a generic competitor for its opioid, saying the deal...
To view the full article, register now.